Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in the KSA.
Campus
  • Payor
Campus
  • Payor

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
T1DM Mini-Series: Severe hypoglycaemia compromises the achievement of glycaemic control

T1DM Mini-Series: Severe hypoglycaemia compromises the achievement of glycaemic control

Learn more
Hear from an expert on what are the main challenges in treating Patients with CRS with Nasal Polyps?

Hear from an expert on what are the main challenges in treating Patients with CRS with Nasal Polyps?

Learn more
Do historical HbA1c values explain glycemic legacy effect in type 2 diabetes?

Do historical HbA1c values explain glycemic legacy effect in type 2 diabetes?

Learn more
T1DM Mini-Series: Clinical implications of having hyperglycaemia with ketosis

T1DM Mini-Series: Clinical implications of having hyperglycaemia with ketosis

Learn more
Hear from an expert on how can you limit the effects of systemic steroid use for Patients with CRS with Nasal Polyps?

Hear from an expert on how can you limit the effects of systemic steroid use for Patients with CRS with Nasal Polyps?

The superiority of Biologics over OCS for disease modifying potential which explains the superiority over OCS as anti-inflammatory option for our patients with CRSwNP, when we prescribe the Biologicals, we prescribe them long term for chronic disease where we do believe that we do not only aim to reduce inflammation but also to have some disease modifying effects.

Learn more
Diabetes Your Type: Testimonial by Dr. Bassam​

Diabetes Your Type: Testimonial by Dr. Bassam​

Learn more
Low risk of VTE Following Early Pregnancy Loss in Pregnancies Conceived by IVF

Low risk of VTE Following Early Pregnancy Loss in Pregnancies Conceived by IVF

Learn more
Rethink your Nasal Polyps. Type 2 Inflammation a Nasal Polyps mystery

Rethink your Nasal Polyps. Type 2 Inflammation a Nasal Polyps mystery

Learn more
Type 2 Inflammation is the underlying cause of CRSwNP in 80% of Patients.

Type 2 Inflammation is the underlying cause of CRSwNP in 80% of Patients.

Learn more
Lipid-lowering therapy and care gap in patients with Familial Hypercholesterolemia

Lipid-lowering therapy and care gap in patients with Familial Hypercholesterolemia

Learn more
T1DM Mini-Series: Edition Junior trial results

T1DM Mini-Series: Edition Junior trial results

Learn more
Lipid-Lowering Therapy and Achievement of Lipid Targets ESC and EAS Guidelines

Lipid-Lowering Therapy and Achievement of Lipid Targets ESC and EAS Guidelines

Learn more